🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Spencer R. Haupert

United States Food and Drug Administration

ORCID: 0000-0001-5959-2301

Also affiliated with Center for Drug Evaluation and Research

MedicinePsychologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia”.

US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia

Journal of Clinical Oncology(2025)10.1200/jco-25-01369

N/A

0.104DataRank · unranked

1 citations

Dianne Pulte, Lori A. Ehrlich, Alexei Ionan, Spencer R. Haupert, Jonathon Vallejo +15 more

A Case-Crossover Phenome-wide association study (PheWAS) for understanding Post-COVID-19 diagnosis patterns

Journal of Biomedical Informatics(2022)10.1016/j.jbi.2022.104237

N/A

0DataRank · unranked

11 citations

Xu Shi, Chen Chen, Lars G. Fritsche, Bhramar Mukherjee, Spencer R. Haupert

A Case-Crossover Phenome-wide Association Study (PheWAS) for Understanding Post-COVID-19 Diagnosis Patterns

medRxiv(2022)10.1101/2022.07.07.22277394

N/A

0DataRank · unranked

0 citations

Xu Shi, Chen Chen, Lars G. Fritsche, Bhramar Mukherjee, Spencer R. Haupert